VVisa Inc.
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $3.48Beat
- vs $3.43 expected on Oct 27
- Stock move on it
- −0.31%
- one session
- Typical move
- ±0.4%
- average over 2 reports
- Price
- $420.33
- −1.23% today · $701B cap
Past and upcoming reports
2
| Oct 27, 2026 | Sep 30, 2026 | Time not given | $3.43 | Beat$3.48 | −0.31% |
| Jul 28, 2026 | Jun 30, 2026 | Time not given | $3.22 | Beat$3.32 | +0.58% |
After the report
Jul 28, 2026 report
This covers the Jul 28, 2026 report. The Oct 27, 2026 numbers are in the table above.
Visa beats Q3 EPS by 2.8%, X Money emerges as growth vector
Visa reported Q3 (Jun) EPS of $3.32, beating the $3.23 estimate by 2.76%. Revenue growth and operating margins remained solid, while management reiterated guidance. The stock edged up 0.6% on the session as investors focused on the X Money adoption narrative as a new growth vector. Valuation remains elevated at 32x TTM P/E, but strong institutional backing and high ROE support the premium.
Reported against expected
BeatEPS of $3.32 beat the consensus $3.23 estimate by $0.09 (+2.76%).
Guidance
KeptManagement reiterated prior guidance. no material change to forward outlook.
How the stock reacted
The stock closed at $368.73, up 0.58% from the previous close of $366.59, reflecting a modest positive reaction.
What changed
EPS beat by 2.8%. X Money adoption emerges as a new growth vector.
What the price now assumes
Market prices steady organic growth with X Money optionality, but P/E premium limits near-term upside.
What it means for the business
Upgrade bias with X Money as a watch trigger. monitor adoption metrics in Q4.
The next one to three months, as we saw it then
Better case20%
Accelerating X Money adoption and sustained consumer spending drive upside to Q4 guidance, supporting a re-rating toward the analyst target of $418.
Base case60%
Visa continues to execute in line with guidance, with steady revenue growth and margin expansion. Valuation remains around current levels.
Worse case20%
Consumer spending softens or regulatory headwinds emerge, compressing the multiple and leading to EPS downgrades.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.